Completed × Neoplasm Metastasis × Gastrointestinal × Clear all COLOCROSS
Phase 3 Completed
89 enrolled
TRIPLET
Phase 2/3 Completed
229 enrolled
Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
Phase 2 Completed
17 enrolled 12 charts
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
7 enrolled 14 charts
SEGWAY
Phase NA Completed
20 enrolled
CIEMAR
Completed
500 enrolled
EARDIS
Completed
120 enrolled
FEGALA
Phase NA Completed
411 enrolled
GENDER-HCC-MET
Completed
19,019 enrolled
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
Phase 1 Completed
53 enrolled
INOVOLINE
Phase NA Completed
101 enrolled
Cabozantinib and Pembrolizumab in Metastatic Pancreas
Phase 2 Completed
21 enrolled 12 charts
"Cancersensor": Circadian Rhythms
Completed
32 enrolled
ConsortiumIO
Phase 1/2 Completed
56 enrolled 11 charts
A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
Phase 1/2 Completed
89 enrolled 24 charts
Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Completed
83 enrolled 21 charts
MULTIDOM
Phase NA Completed
58 enrolled
EchoTip AcuCore Post-Market Clinical Study
Completed
183 enrolled
Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
Phase 1/2 Completed
48 enrolled 16 charts
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Phase 1/2 Completed
145 enrolled 47 charts
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Phase 3 Completed
545 enrolled 24 charts
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Phase 1 Completed
260 enrolled 52 charts
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Phase 1 Completed
185 enrolled 28 charts
Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy
Phase 2 Completed
32 enrolled 14 charts
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
Phase 2 Completed
44 enrolled 19 charts
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
Completed
90 enrolled
AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer
Phase 2 Completed
13 enrolled 8 charts
MAESTRO
Phase 3 Completed
693 enrolled 8 charts
A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors
Phase 1 Completed
43 enrolled
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Phase 1/2 Completed
64 enrolled 20 charts
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Phase 1 Completed
38 enrolled
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers
Phase 1 Completed
13 enrolled 17 charts
LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Completed
44 enrolled
Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies
Completed
24 enrolled
ZETA
Completed
120 enrolled
MAP-RT
Phase NA Completed
20 enrolled 8 charts
Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Phase 2 Completed
24 enrolled
REPROGRAM-01
Phase 2 Completed
49 enrolled
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Phase 1 Completed
48 enrolled
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Phase 1 Completed
12 enrolled
MB
Phase NA Completed
200 enrolled
M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability
Phase 1/2 Completed
4 enrolled 7 charts
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
Phase 1 Completed
29 enrolled
Study of Continuous OSI-906 Dosing
Phase 1 Completed
95 enrolled
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Phase 1 Completed
29 enrolled
GEN2
Phase 1 Completed
61 enrolled
A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
Phase 3 Completed
512 enrolled 27 charts
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery
Phase 1 Completed
11 enrolled 26 charts
Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer
Phase 2 Completed
53 enrolled 14 charts